Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Cell–cell interactions as predictive and prognostic markers for drug responses in cancer
by
Agrawal, Divya
, Tan, Xiao
, Jin, Xinnan
, Monkman, James
, de los Reyes Becerra Perez, Maria Reyes Becerra
, Tuong, Zewen Kelvin
, Kim, Eun Ju
, Lu, Xuehan
, Donovan, Meg L.
, Kulasinghe, Arutha
, Xiong, Zherui
, Nguyen, Quan
, Cruz, Jazmina L. Gonzalez
, Gong, Jialei
in
Antineoplastic Agents - pharmacology
/ Antineoplastic Agents - therapeutic use
/ Bioinformatics
/ Biomarkers
/ Biomarkers, Tumor - metabolism
/ Biomedical and Life Sciences
/ Biomedicine
/ Breast cancer
/ Cancer
/ Cancer Research
/ Cancer therapies
/ Cell Communication
/ Cell interactions
/ Cells
/ Cell–cell colocalization
/ Cell–cell interactions
/ Clinical trials
/ Computational Biology - methods
/ Cytokines
/ Drug responses
/ Drug therapy
/ Forecasts and trends
/ Genes
/ Geospatial data
/ Health aspects
/ Histopathology
/ Human Genetics
/ Humans
/ Immunotherapy
/ Ipilimumab
/ Ligands
/ Medicine/Public Health
/ Metabolomics
/ Neoplasms - drug therapy
/ Neoplasms - genetics
/ Neoplasms - metabolism
/ Neoplasms - pathology
/ Precision Medicine
/ Prognosis
/ Proteins
/ Proteomics
/ Review
/ Spatial-omics
/ Systems Biology
/ Therapeutic targets
/ Transcriptomics
/ Tumor microenvironment
/ Tumor Microenvironment - drug effects
2025
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Cell–cell interactions as predictive and prognostic markers for drug responses in cancer
by
Agrawal, Divya
, Tan, Xiao
, Jin, Xinnan
, Monkman, James
, de los Reyes Becerra Perez, Maria Reyes Becerra
, Tuong, Zewen Kelvin
, Kim, Eun Ju
, Lu, Xuehan
, Donovan, Meg L.
, Kulasinghe, Arutha
, Xiong, Zherui
, Nguyen, Quan
, Cruz, Jazmina L. Gonzalez
, Gong, Jialei
in
Antineoplastic Agents - pharmacology
/ Antineoplastic Agents - therapeutic use
/ Bioinformatics
/ Biomarkers
/ Biomarkers, Tumor - metabolism
/ Biomedical and Life Sciences
/ Biomedicine
/ Breast cancer
/ Cancer
/ Cancer Research
/ Cancer therapies
/ Cell Communication
/ Cell interactions
/ Cells
/ Cell–cell colocalization
/ Cell–cell interactions
/ Clinical trials
/ Computational Biology - methods
/ Cytokines
/ Drug responses
/ Drug therapy
/ Forecasts and trends
/ Genes
/ Geospatial data
/ Health aspects
/ Histopathology
/ Human Genetics
/ Humans
/ Immunotherapy
/ Ipilimumab
/ Ligands
/ Medicine/Public Health
/ Metabolomics
/ Neoplasms - drug therapy
/ Neoplasms - genetics
/ Neoplasms - metabolism
/ Neoplasms - pathology
/ Precision Medicine
/ Prognosis
/ Proteins
/ Proteomics
/ Review
/ Spatial-omics
/ Systems Biology
/ Therapeutic targets
/ Transcriptomics
/ Tumor microenvironment
/ Tumor Microenvironment - drug effects
2025
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Cell–cell interactions as predictive and prognostic markers for drug responses in cancer
by
Agrawal, Divya
, Tan, Xiao
, Jin, Xinnan
, Monkman, James
, de los Reyes Becerra Perez, Maria Reyes Becerra
, Tuong, Zewen Kelvin
, Kim, Eun Ju
, Lu, Xuehan
, Donovan, Meg L.
, Kulasinghe, Arutha
, Xiong, Zherui
, Nguyen, Quan
, Cruz, Jazmina L. Gonzalez
, Gong, Jialei
in
Antineoplastic Agents - pharmacology
/ Antineoplastic Agents - therapeutic use
/ Bioinformatics
/ Biomarkers
/ Biomarkers, Tumor - metabolism
/ Biomedical and Life Sciences
/ Biomedicine
/ Breast cancer
/ Cancer
/ Cancer Research
/ Cancer therapies
/ Cell Communication
/ Cell interactions
/ Cells
/ Cell–cell colocalization
/ Cell–cell interactions
/ Clinical trials
/ Computational Biology - methods
/ Cytokines
/ Drug responses
/ Drug therapy
/ Forecasts and trends
/ Genes
/ Geospatial data
/ Health aspects
/ Histopathology
/ Human Genetics
/ Humans
/ Immunotherapy
/ Ipilimumab
/ Ligands
/ Medicine/Public Health
/ Metabolomics
/ Neoplasms - drug therapy
/ Neoplasms - genetics
/ Neoplasms - metabolism
/ Neoplasms - pathology
/ Precision Medicine
/ Prognosis
/ Proteins
/ Proteomics
/ Review
/ Spatial-omics
/ Systems Biology
/ Therapeutic targets
/ Transcriptomics
/ Tumor microenvironment
/ Tumor Microenvironment - drug effects
2025
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Cell–cell interactions as predictive and prognostic markers for drug responses in cancer
Journal Article
Cell–cell interactions as predictive and prognostic markers for drug responses in cancer
2025
Request Book From Autostore
and Choose the Collection Method
Overview
The tumor microenvironment (TME) is composed of a diverse and dynamic spectrum of cell types, cellular activities, and cell–cell interactions (CCI). Understanding the complex CCI within the TME is critical for advancing cancer treatment strategies, including modulating or predicting drug responses. Recent advances in omics technologies, including spatial transcriptomics and proteomics, have allowed improved mapping of CCI within the TME. The integration of omics insights from different platforms may facilitate the identification of novel biomarkers and therapeutic targets. This review discusses the latest computational methods for inferring CCIs from different omics data and various CCI and drug databases, emphasizing their applications in predicting drug responses. We also comprehensively summarize recent patents, clinical trials, and publications that leverage these cellular interactions to refine cancer treatment approaches. We believe that the integration of these CCI-focused technologies can improve personalized therapy for cancer patients, thereby optimizing treatment outcomes and paving the way for next-generation precision oncology.
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
This website uses cookies to ensure you get the best experience on our website.